SVT-15652 Otic Solution for the Treatment of Otomycosis
Status:
Recruiting
Trial end date:
2021-11-01
Target enrollment:
Participant gender:
Summary
Multicenter, randomized, 2-arm parallel-group, double blind, placebo-controlled study in
patients suffering from Otomycosis. This study will compare the efficacy and safety of
SVT-15652 otic solution to that of Placebo, when administering one vial twice daily during 14
days.